BridgeMD
New treatment option for Huntington's Disease (HD)
Official title Social Cognition Training in Individuals With Huntington's Disease
ClinicalTrials.gov ID: NCT06828471
What this study is testing
- What it's testing
- Individuals with Huntington's Disease have impaired social cognition, which is the domain of cognition that allows individuals to understand others' perspectives so that they can navigate interpersonal actions successfully (e.g., understanding someone may be sad based of their facial emotion or tone of voice and then responding in a sympathetic manner). Impaired social cognition is associated with impaired social functioning, poor psychological wellbeing and increased caregiver burden, which is known to be significant among those who care for individuals with Huntington's Disease.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- for Individual with Huntington's Disease
- Diagnosed with Huntington's Disease based on genetic testing
- Must be between 18 and 65 years of age
- Native English speaker who is literate in English
- Stable psychotropic medication regimen for 4 weeks
You likely can't join if
- for Individual with Huntington's Disease
- Any known neurological condition (other than Huntington's Disease).
- History of learning and/or intellectual disabilities
- Currently actively involved in any other treatment trial (i.e. have begun the intervention) or within 4 weeks of completing the final assessments of...
- Currently regularly completing a computerized cognitive training intervention.
- Active suicidal ideation with some intent Exclusion Criteria for Caregiver of Individual with Huntington's Disease
See the full eligibility criteria
- for Individual with Huntington's Disease
- Diagnosed with Huntington's Disease based on genetic testing
- Must be between 18 and 65 years of age
- Native English speaker who is literate in English
- Stable psychotropic medication regimen for 4 weeks
- Must have a score of "somewhat easily" on all items in the CPQ-12
- MOCA \>18
- Completed 12 years of schooling
- Access to laptop or mobile device
- Willingness to come in person 6-12 weeks after first visit for Caregiver of Individual with Huntington's Disease
- Lives with patient
- Must be between 18 and 65 years of age
- Native English speaker who is literate in English
- MOCA \>26
- Willingness to come in person within 6-12 weeks after first visit
- for Individual with Huntington's Disease
- Any known neurological condition (other than Huntington's Disease).
- History of learning and/or intellectual disabilities
- Currently actively involved in any other treatment trial (i.e. have begun the intervention) or within 4 weeks of completing the final assessments of an treatment trial.
- Currently regularly completing a computerized cognitive training intervention.
- Active suicidal ideation with some intent Exclusion Criteria for Caregiver of Individual with Huntington's Disease
- Inability to provide informed consent
- Active suicidal ideation with some intent
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.